Simplifying Oncology NGS Implementation with an IVD Test: Verification, Informatics, Reporting, and Reimbursement - Poll - MDSpire

Simplifying Oncology NGS Implementation with an IVD Test: Verification, Informatics, Reporting, and Reimbursement

Join us to learn how an IVD approach can support a more streamlined path from implementation planning to daily operations.

  • June 30, 2026

Share

Original Source(s)

Simplifying Oncology NGS Implementation with an IVD Test: Verification, Informatics, Reporting, and Reimbursement

  • June 30, 2026

Related Content

The Culture Clash that Shaped Me

Sitting Down With... Cristina Magi-Galluzzi, Chair of the University of Alabama at Birmingham Department of Pathology, and President of USCAP

FDA Approves New First-Line TNBC Regimen

Phase 3 results showed longer progression-free survival with pembrolizumab plus sacituzumab govitecan-hziy than with pembrolizumab plus chemotherapy in previously untreated PD-L1-positive advanced triple-negative breast cancer.

Tau368 improves p-tau diagnostic accuracy for FTLD-tau from FTLD-TDP